Sale!

STAC3 Gene Native American Myopathy Genetic Test

4,400 د.إ

-21%

The STAC3 Gene Native American Myopathy Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the STAC3 gene, which are associated with Native American Myopathy (NAM). Native American Myopathy is a rare, genetic disorder predominantly found among Native American populations, characterized by muscle weakness, skeletal abnormalities, and potential respiratory and cardiac complications. The condition is inherited in an autosomal recessive manner, meaning that two copies of the mutated gene, one from each parent, are necessary for a child to be affected.

This genetic test is crucial for early diagnosis and management of the condition, enabling healthcare providers to offer targeted treatments and interventions that can significantly improve the quality of life for individuals with NAM. By analyzing a patient’s DNA sample, usually obtained through a blood draw, the test specifically looks for the known mutations within the STAC3 gene that are responsible for the disorder.

The cost of the STAC3 Gene Native American Myopathy Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the comprehensive process of collecting the sample, conducting the genetic analysis, and interpreting the results to provide a conclusive diagnosis. It is a valuable resource for families with a history of the condition or for individuals showing symptoms consistent with Native American Myopathy, offering them a clear understanding of their genetic status and guiding them towards appropriate medical care and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

STAC3 Gene Native American myopathy Genetic Test

At DNA Labs UAE, we offer the STAC3 Gene Native American myopathy Genetic Test to help diagnose and manage this rare genetic disorder. This test analyzes the DNA sequence of the STAC3 gene using NGS (Next-Generation Sequencing) technology.

Test Components and Price

The STAC3 Gene Native American myopathy Genetic Test is priced at 4400.0 AED. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery

After the sample is collected, the report will be delivered within 3 to 4 weeks.

Method

The STAC3 Gene Native American myopathy Genetic Test utilizes NGS technology to sequence the entire coding region of the STAC3 gene and other relevant genes.

Test Type and Doctor

The test falls under the category of Dysmorphology and is conducted by our experienced Pediatrics doctors.

Test Department

The STAC3 Gene Native American myopathy Genetic Test is carried out in our Genetics department.

Pre Test Information

Prior to undergoing the STAC3 Gene Native American myopathy NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counseling session will be conducted to draw a pedigree chart of family members affected by the STAC3 Gene Native American myopathy.

Test Details

The STAC3 gene is associated with Native American myopathy (NAM), a rare genetic disorder characterized by muscle weakness and wasting, particularly in the limbs. This disorder primarily affects individuals of Native American descent.

NGS genetic testing is used to analyze the DNA sequence of the STAC3 gene and identify any mutations or variations that may be present. This testing method can confirm a diagnosis of Native American myopathy and provide information about the specific genetic variant causing the condition.

NGS testing involves sequencing the entire coding region of the STAC3 gene, as well as other relevant genes, to detect any abnormalities. It can identify small genetic changes, such as single nucleotide variants (SNVs) or small insertions or deletions (indels), as well as larger structural variations.

Genetic testing for Native American myopathy is beneficial for individuals suspected of having the condition, as it provides a definitive diagnosis and helps guide treatment and management options. It is also useful for family members who may be at risk of inheriting the condition, as it provides information about their carrier status and the likelihood of passing the condition on to future generations.

Test Name STAC3 Gene Native American myopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for STAC3 Gene Native American myopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with STAC3 Gene Native American myopathy NGS Genetic DNA Test gene STAC3
Test Details

The STAC3 gene is associated with a rare genetic disorder called Native American myopathy (NAM). NAM is characterized by muscle weakness and wasting, particularly in the limbs. It primarily affects individuals of Native American descent.

NGS (Next-Generation Sequencing) genetic testing can be used to analyze the DNA sequence of the STAC3 gene to identify any mutations or variations that may be present. This type of testing can help confirm a diagnosis of Native American myopathy and provide information about the specific genetic variant causing the condition.

NGS testing involves sequencing the entire coding region of the STAC3 gene, as well as other relevant genes, to detect any abnormalities. It can identify small genetic changes, such as single nucleotide variants (SNVs) or small insertions or deletions (indels), as well as larger structural variations.

Genetic testing for Native American myopathy can be helpful for individuals suspected of having the condition, as it can provide a definitive diagnosis and help guide treatment and management options. It can also be useful for family members who may be at risk of inheriting the condition, as it can provide information about their carrier status and the likelihood of passing the condition on to future generations.